ERBB2 and breast carcinoma: We observed that tumor cells in this model showed varying expression levels of luminal cell markers (cytokeratins 8/18 and 19), basal cell markers (cytokeratin 5 and SMA) and other breast cancer epithelial markers such as HER2 and CD44 (Fig. 3d and Supplementary Videos 7 and 8).